Pharmanutra Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	642	523	542	601	730	364
Market Cap Growth	24.99%	-3.62%	-9.76%	-17.67%	100.53%	60.68%
Enterprise Value	641	523	552	595	710	350
Last Close Price	66.90	53.41	54.47	59.24	70.91	34.72
PE Ratio	36.79	31.47	42.26	39.94	53.01	25.87
Forward PE	28.36	25.25	32.36	38.79	53.54	23.04
PS Ratio	5.05	4.50	5.39	7.24	10.71	6.41
PB Ratio	9.72	8.40	9.97	11.80	16.19	9.65
P/TBV Ratio	15.41	12.79	16.38	19.87	18.30	11.18
P/FCF Ratio	61.63	32.16	-	-	47.32	35.98
P/OCF Ratio	44.47	25.50	44.85	34.41	35.76	30.85
PEG Ratio	-	1.77	1.77	1.77	1.77	1.77
EV/Sales Ratio	5.04	4.50	5.49	7.16	10.41	6.17
EV/EBITDA Ratio	20.26	17.29	21.72	24.56	36.76	23.19
EV/EBIT Ratio	22.77	19.11	24.00	25.78	38.78	24.71
EV/FCF Ratio	61.54	32.17	-	-	46.00	34.61
Debt / Equity Ratio	0.32	0.39	0.52	0.35	0.14	0.04
Debt / EBITDA Ratio	0.66	0.79	1.10	0.73	0.33	0.11
Debt / FCF Ratio	2.01	1.49	-	-	0.41	0.16
Net Debt / Equity Ratio	-0.01	-0.08	0.05	-0.18	-0.61	-0.51
Net Debt / EBITDA Ratio	-0.03	-0.16	0.11	-0.38	-1.43	-1.27
Net Debt / FCF Ratio	-0.09	-0.30	-2.50	1.05	-1.79	-1.89
Asset Turnover	1.08	1.01	0.95	0.97	1.11	1.13
Inventory Turnover	6.81	7.53	7.76	10.13	15.13	16.15
Quick Ratio	1.60	1.95	1.70	1.96	3.08	3.39
Current Ratio	2.19	2.38	2.12	2.28	3.32	3.63
Return on Equity (ROE)	27.73%	28.39%	24.36%	31.34%	33.26%	42.73%
Return on Assets (ROA)	14.96%	14.88%	13.54%	16.82%	18.58%	17.61%
Return on Invested Capital (ROIC)	25.90%	29.08%	25.63%	50.00%	74.25%	82.60%
Return on Capital Employed (ROCE)	31.80%	30.40%	27.20%	31.00%	33.50%	34.90%
Earnings Yield	2.72%	3.18%	2.37%	2.50%	1.89%	3.87%
FCF Yield	1.62%	3.11%	-0.21%	-1.45%	2.11%	2.78%
Dividend Yield	1.53%	1.87%	1.56%	1.35%	1.00%	1.93%
Payout Ratio	54.97%	49.20%	60.11%	45.53%	47.10%	31.64%
Buyback Yield / Dilution	0.58%	0.61%	0.05%	0.09%	-	-
Total Shareholder Return	2.07%	2.48%	1.61%	1.44%	1.00%	1.93%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.